Delivery Order SPE2DE24D0013-SPE2D626F97N2
- Not listed
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,800 on January 6, 2026, under a Defense Logistics Agency Medical Supply Chain contract. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic systems and reagents. The award carries no set-aside designation, reflecting Cepheid's competitive positioning...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $3,638 for COVID-19/Influenza/RSV diagnostic supplies. The delivery order, issued on December 10, 2025, with an ultimate completion date of December 24, 2025, represents a routine procurement action under the DLA Medical Supply Chain's established contracting framework for infectious disease testing solutions. No...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on December 2, 2025, under contract 4570154100 (XPRS4PLEX-10) with an ultimate completion date of December 9, 2025. This delivery order, which received no set-aside designation, is for diagnostic testing supplies and reagents to be delivered to the place of performance in Sunnyvale, California. Cepheid, a leading federal supplier of molecular diagnostic systems headquartered in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F97N2Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls under Cepheid's established relationship with federal medical supply chains, where the company serves as a primary supplier of GeneXpert diagnostic platforms and associated molecular testing capabilities for infectious diseases including COVID-19, influenza, respiratory infections, and other clinical conditions. This delivery order is issued under Cepheid's broader indefinite delivery contract framework with the Department of Veterans Affairs, specifically supporting ongoing procurement of diagnostic reagents and test kits across the VA's integrated service networks. Cepheid has demonstrated substantial capacity as a federal supplier through multiple prime contracts and delivery orders spanning the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, with contract values historically ranging from under $100,000 to multi-million dollar agreements. The company's role in supporting federal diagnostic testing requirements extends beyond routine procurement to include research collaboration on drug-resistant tuberculosis detection and international capacity-building initiatives, underscoring its technical expertise and strategic importance to federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/8/26 |